IMI CANCER-ID: Validation of novel blood-based biomarker technologies in clinical settings

被引：0
|
作者：
Schange, Thomas [1 ]
Krahn, Thomas [1 ]
Pleier, Sabrina [1 ]
Pantel, Klaus [2 ]
Terstappen, Leon W. M. M. [3 ]
Baggiani, Barbara [4 ]
机构：
[1] Bayer Pharma AG, Wuppertal, Germany
[2] Univ Klin Eppendorf, Hamburg, Germany
[3] Univ Twente, Twente, Netherlands
[4] Menarini Silicon Biosyst, Bologna, Italy
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-1604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1604
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinical applications of a novel blood-based fragmentomics assay for lung cancer detection
    Siegel, M.
    Kibler, J.
    Fathe, K.
    Carson, A.
    Leatham, B.
    Wang, M.
    Cabrera, K.
    Smith, M.
    Salmans, M.
    Lee, B. I.
    Francis, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S767 - S767
  • [32] Review: Microfluidics technologies for blood-based cancer liquid biopsies
    Sun, Yuxi
    Haglund, Thomas A.
    Rogers, Aaron J.
    Ghanim, Asem F.
    Sethu, Palaniappan
    ANALYTICA CHIMICA ACTA, 2018, 1012 : 10 - 29
  • [33] Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer
    Bhardwaj, Megha
    Terzer, Tobias
    Schrotz-King, Petra
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 17
  • [34] Validation of a Blood-Based Biomarker Test for the Diagnosis and Management of Bronchopulmonary Neuroendocrine Tumors
    Modlin, I
    Kidd, M.
    Lewczuk-Myslinska, A.
    Chung, K. M.
    Cwikla, J.
    Lowczak, A.
    Doboszynska, A.
    Tesselaar, M.
    Buikhuisen, W.
    Malczewska, A.
    Kos-Kudla, B.
    Roffinella, M.
    NEUROENDOCRINOLOGY, 2018, 106 : 294 - 294
  • [35] NOVEL BLOOD-BASED BIOMARKER MODEL FOR DIAGNOSIS OF HEPATIC FIBROSIS IN MASLD
    Verschuren, Eveline Gart Lars
    Mak, Anne
    Boonstra, Andre
    Verheij, Joanne
    Gluud, Lise Lotte
    Holleboom, Adriaan
    Tushuizen, Maarten
    HEPATOLOGY, 2024, 80 : S1546 - S1547
  • [36] Novel blood-based protein biomarker signature for prediction of heart failure
    Tonry, C. Claire
    Mcdonald, K.
    Ledwidge, M.
    Hernandez, B.
    Glezeva, N.
    Rooney, C.
    Morrissey, B.
    Pennington, S. R.
    Baugh, J. A.
    Watson, C. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 171 - 171
  • [37] KDM3A, a Novel Blood-Based Biomarker in Colorectal Carcinogenesis
    Polat, D.
    Onur, E.
    Yilmaz, N.
    Sokucu, M.
    Gerceker, O. F.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2022, 25 (02) : 23 - 27
  • [38] Validation of a Blood-Based Protein Biomarker Panel for a Risk Assessment of Lethal Lung Cancer in the Physicians' Health Study
    Song, Lulu
    Irajizad, Ehsan
    Rundle, Andrew
    Sesso, Howard D.
    Gaziano, John Michael
    Vykoukal, Jody V.
    Do, Kim-Anh
    Dennison, Jennifer B.
    Ostrin, Edwin J.
    Fahrmann, Johannes F.
    Perera, Frederica
    Hanash, Samir
    CANCERS, 2024, 16 (11)
  • [39] A blood-based biomarker panel for stratifying current risk for colorectal cancer
    Marshall, Kenneth Wayne
    Mohr, Steve
    El Khettabi, Faysal
    Nossova, Nadejda
    Chao, Samuel
    Bao, Weisheng
    Ma, Jun
    Li, Xiao-jun
    Liew, Choong-Chin
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (05) : 1177 - 1186
  • [40] Blood-based DNA methylation as biomarker for breast cancer: a systematic review
    Qiuqiong Tang
    Jie Cheng
    Xue Cao
    Harald Surowy
    Barbara Burwinkel
    Clinical Epigenetics, 2016, 8
12345